Injections and infusions

‘World first’ anticancer jab to reduce treatment times by 75%, says NHS England

NHS England has announced that it will offer atezolizumab via subcutaneous injection, bringing treatment times down from 30 minutes to as little as 7 minutes.…

Increasing injectable medicines ten-fold could release time equivalent to 4,000 extra nurses, report says

The production of injectable medicines in England could be increased from the current 3.4 million individual doses to more than 40 million per year.…

Diabetes: mental health considerations in adults

Pharmacists can contribute to the psychological and emotional wellbeing of people living with diabetes by helping to identify those who have mental wellbeing needs, optimising treatment and minimising risk factors.…

Medicine safety expert warns against ‘unlawful’ guidance to discard IV infusion sets

Following national guidance to discard an intravenous infusion set without flushing it is “unlawful”, the former head of safe medication practice at the National Patient Safety Agency has warned.…

Patients are being underdosed: we need new guidance on small-volume drug infusions

Too many patients are not receiving their full prescribed dose with small-volume drug infusions, but hospital pharmacists can act to ensure patient safety.…

Dealing with medicines misuse in execution by lethal injection

New standards of industry best practice have been established for implementing distribution controls on drugs that could be used for execution…

All you need to know about using smart infusion pumps

Smart infusion pumps: implementation, management and drug libraries, 2nd edition, edited by Pamela K Phelps.…

New guidance for hepatitis B vaccine shortage

Public Health England has issued “temporary” guidance that restricts providing hepatitis B immunisation to adults and children, in response to the global shortage of the vaccine.…

Frequent intravitreal bevacizumab injections increase risk of glaucoma surgery

Seven or more injections a year makes patients more than twice as likely to need glaucoma surgery, according to researchers.…

FDA approves first monoclonal antibody injection for atopic dermatitis

The US Food and Drug Administration (FDA), which is responsible for evaluating the safety and efficacy of medicines in the United States, has approved the use of dupilumab (Dupixent; Regeneron Pharmaceuticals) to treat adults with atopic dermatitis. Dupilumab is the first monoclonal antibody t…